Phytosterols ameliorate clinical manifestations and inflammation in experimental autoimmune encephalomyelitis

Inflammation Research

Volumn 60, Issue 5, 2011, Pages 457-465

  Valerio, Michael ^a   Liu, Hong Biao ^a   Heffner, Reid ^a   Zivadinov, Robert ^b,c   Ramanathan, Murali ^a,b   Weinstock Guttman, Bianca ^b   Awad, Atif B ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b BUFFALO GENERAL HOSPITAL   (United States)

^c JACOBS NEUROLOGICAL INSTITUTE   (United States)

Author keywords

CCL2; Demyelination; EAE; IL 10; Macrophages; Phytosterols

Indexed keywords

INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PHYTOSTEROL; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN;

ANIMAL FEED; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTES; MACROPHAGES; MICE; MULTIPLE SCLEROSIS; PEPTIDES; PHYTOSTEROLS; TIME FACTORS;

EID: 79955933572     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0288-z     Document Type: Article

References (47)

1. Kizelsztein P, Komarnytsky S, Raskin I. Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex. J Neuroimmunol. 2009;217(1-2):28-37.
2. Olsson T. Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology. 1995;45(6 Suppl 6):S11-5.
3. Christophi GP, Panos M, Hudson CA, Christophi RL, Gruber RC, Mersich AT, Blystone SD, Jubelt B, Massa PT. Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype. Lab Invest. 2009;89(7):742-59.
4. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009;132(Pt 5):1175-89.
5. Peiris M, Monteith GR, Roberts-Thomson SJ, Cabot PJ. A model of experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice for the characterisation of intervention therapies. J Neurosci Methods. 2007;163(2):245-54. (Pubitemid 46874602)
6. Wingerchuk D. Multiple sclerosis: current pathophysiological concepts. Lab Invest. 2001;81(3):263-81. (Pubitemid 32245059)
7. De Paula M, et al. Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis. Int Immunopharmacol. 2008;8:1291-7.
8. Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain. 2006;129(Pt 8):1953-71. (Pubitemid 44289062)
9. Liu H, MacKenzie-Graham AJ, Palaszynski K, Liva S, Voskuhl RR. "Classic" myelin basic proteins are expressed in lymphoid tissue macrophages. J Neuroimmunol. 2001;116(1):83-93. (Pubitemid 32322642)
10. Archambault AS, Sim J, McCandless EE, Klein RS, Russell JH. Region-specific regulation of inflammation and pathogenesis in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2006;181(1-2):122-32. (Pubitemid 44830141)
11. Hemmer B, Cepok S, Nessler S, Sommer N. Pathogenesis of multiple sclerosis: an update on immunology. Curr Opin Neurol. 2002;15(3):227-31. (Pubitemid 34596882)
12. Proudfoot AE, de Souza AL, Muzio V. The use of chemokine antagonists in EAE models. J Neuroimmunol. 2008;198(1-2):27-30.
13. Doring A, Wild M, Vestweber D, Deutsch U, Engelhardt B. Eand P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. J Immunol. 2007;179(12):8470-9.
14. Brini E, Ruffini F, Bergami A, Brambilla E, Dati G, Greco B, Cirillo R, Proudfoot AE, Comi G, Furlan R, et al. Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss. J Neuroimmunol. 2009;209(1-2):33-9.
15. Dogan RN, Elhofy A, Karpus WJ. Production of CCL2 by central nervous system cells regulates development of murine experimental autoimmune encephalomyelitis through the recruitment of TNF- and iNOS-expressing macrophages and myeloid dendritic cells. J Immunol. 2008;180(11):7376-84.
16. Kalehua AN, Nagel JE, Whelchel LM, Gides JJ, Pyle RS, Smith RJ, Kusiak JW, Taub DD. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration. Exp Cell Res. 2004;297(1):197-211. (Pubitemid 38759573)
17. Rajan AJ, Asensio VC, Campbell IL, Brosnan CF. Experimental autoimmune encephalomyelitis on the SJL mouse: effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system. J Immunol. 2000;164(4):2120-30. (Pubitemid 30108771)
18. Bradford PG, Awad AB. Phytosterols as anticancer compounds. Mol Nutr Food Res. 2007;51(2):161-70. (Pubitemid 47083247)
19. Moreau RA, Whitaker BD, Hicks KB. Phytosterols, phytostanols, and their conjugates in foods: structural diversity, quantitative analysis, and health-promoting uses. Prog Lipid Res. 2002;41(6):457-500.
20. Winkler JK, Warner K. Effect of phytosterol structure on thermal polymerization of heated soybean oil. Eur J Lipid Sci Technol. 2008;110(11):1068-77.
21. Ostlund RE Jr. Phytosterols in human nutrition. Annu Rev Nutr. 2002;22:533-49.
22. Ostlund RE Jr. Phytosterols and cholesterol metabolism. Curr Opin Lipidol. 2004;15(1):37-41.
23. Delaney B, Stevens LA, Schmelzer W, Haworth J, McCurry S, Hilfinger JM, Kim JS, Tsume Y, Amidon GL, Kritchevsky D. Oral absorption of phytosterols and emulsified phytosterols by Sprague-Dawley rats. J Nutr Biochem. 2004;15(5):289-95. (Pubitemid 38595479)
24. Desai F, Ramanathan M, Fink CS, Wilding GE, Weinstock- Guttman B, Awad AB. Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients. Int Immunopharmacol. 2009;9(1):153-7.
25. Calpe-Berdiel L, Escola-Gil JC, Benitez S, Bancells C, Gonzalez-Sastre F, Palomer X, Blanco-Vaca F. Dietary phytosterols modulate T-helper immune response but do not induce apparent anti-inflammatory effects in a mouse model of acute, aseptic inflammation. Life Sci. 2007;80(21):1951-6. (Pubitemid 46601515)
26. Voskuhl RR. Chronic relapsing experimental allergic encephalomyelitis in the SJL mouse: relevant techniques. Methods. 1996;10(3):435-9. (Pubitemid 26391941)
27. Mosayebi G, Ghazavi A, Salehi H, Payani MA, Khazae MR. Effect of sesame oil on the inhibition of experimental autoimmune encephalomyelitis in C57BL/6 mice. Pak J Biol Sci. 2007;10(11):1790-6. (Pubitemid 46607926)
28. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med. 2008;205(7):1535-41. (Pubitemid 351962016)
29. Offner H, Polanczyk M. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Ann N Y Acad Sci. 2006;1089:343-72. (Pubitemid 47092076)
30. Zavala F, Abad S, Ezine S, Taupin V, Masson A, Bach JF. G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation. J Immunol. 2002;168(4):2011-9. (Pubitemid 34135805)
31. Fux M, van Rooijen N, Owens T. Macrophage-independent T cell infiltration to the site of injury-induced brain inflammation. J Neuroimmunol. 2008;203(1):64-72.
32. Hac-Wydro K, Wydro P, Jagoda A, Kapusta J. The study on the interaction between phytosterols and phospholipids in model membranes. Chem Phys Lipids. 2007;150(1):22-34. (Pubitemid 47538546)
33. Awad AB, Chinnam M, Fink CS, Bradford PG. beta-Sitosterol activates Fas signaling in human breast cancer cells. Phytomedicine. 2007;14(11):747-54. (Pubitemid 47539097)
34. Awad AB, Barta SL, Fink CS, Bradford PG. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism. Mol Nutr Food Res. 2008;52(4):419-26.
35. Awad AB, Fink CS, Trautwein EA, Ntanios FY. beta-Sitosterol stimulates ceramide metabolism in differentiated Caco2 cells. J Nutr Biochem. 2005;16(11):650-5. (Pubitemid 41456707)
36. Cartier L, Hartley O, Dubois-Dauphin M, Krause KH. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev. 2005;48(1):16-42. (Pubitemid 40215781)
37. Reinke EK, Lee J, Zozulya A, Karman J, Muller WA, Sandor M, Fabry Z. Short-term sPECAM-Fc treatment ameliorates EAE while chronic use hastens onset of symptoms. J Neuroimmunol. 2007;186(1-2):86-93. (Pubitemid 46770866)
38. Youssef S, Stuve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. 2002;420(6911):78-84. (Pubitemid 35291443)
39. Reiss AB, Wirkowski E. Role of HMG-CoA reductase inhibitors in neurological disorders: progress to date. Drugs. 2007;67(15):2111-20. (Pubitemid 47557089)
40. Weber MS, Youssef S, Dunn SE, Prod'homme T, Neuhaus O, Stuve O, Greenwood J, Steinman L, Zamvil SS. Statins in the treatment of central nervous system autoimmune disease. J Neuroimmunol. 2006;178(1-2):140-8. (Pubitemid 44314180)
41. Vollmer T, Key L, Durkalski V, Tyor W, Corboy J, Markovic-Plese S, Preiningerova J, Rizzo M, Singh I. Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet. 2004;363(9421):1607-8. (Pubitemid 38625664)
42. Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol. 2002;2(10):787-95. (Pubitemid 37328718)
43. La Flamme AC, Ruddenklau K, Backstrom BT. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immunol. 2003;71(9):4996-5004. (Pubitemid 37070742)
44. Pedersen LB, Nashold FE, Spach KM, Hayes CE. 1,25-dihydroxyvitamin D-3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res. 2007;85(11):2480-90. (Pubitemid 47204762)
45. Paintlia AS, Paintlia MK, Singh I, Singh AK. Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D- ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis. Am J Pathol. 2006;169(3):1012-25. (Pubitemid 44411963)
46. Ni J, Shu YY, Zhu YN, Fu YF, Tang W, Zhong XG, Wang H, Yang YF, Ren J, Wang MW, et al. COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-gamma and IL-10 production by inhibiting T-bet expression. J Neuroimmunol. 2007;186(1-2):94-103. (Pubitemid 46770867)
47. Nath N, Giri S, Prasad R, Singh AK, Singh I. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. J Immunol. 2004;172(2):1273-86. (Pubitemid 38113791)